US Regulators Weigh Testosterone for Women
US health regulators reviewed testosterone use for menopausal women at a public meeting. Experts debated the need for female-specific products against long-term safety concerns.
Xurve View
Insights:
Xurve View
United States regulators reviewed testosterone therapy for menopausal women during an agency meeting on Thursday, balancing patient demand against clinical safety gaps. The public workshop examines off-label hormone use as a growing number of women seek symptom relief. No FDA-approved testosterone treatments currently exist for female patients domestically, unlike in international markets.
